99 related articles for article (PubMed ID: 26058752)
21. MicroRNA-429 inhibits the migration and invasion of colon cancer cells by targeting PAK6/cofilin signaling.
Tian X; Wei Z; Wang J; Liu P; Qin Y; Zhong M
Oncol Rep; 2015 Aug; 34(2):707-14. PubMed ID: 26058485
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
Zhao X; Zhao Z; Xu W; Hou J; Du X
Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771
[TBL] [Abstract][Full Text] [Related]
23. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
Yu QQ; Wu H; Huang X; Shen H; Shu YQ; Zhang B; Xiang CC; Yu SM; Guo RH; Chen L
Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene.
Yang J; Zhang Z; Chen C; Liu Y; Si Q; Chuang TH; Li N; Gomez-Cabrero A; Reisfeld RA; Xiang R; Luo Y
Oncogene; 2014 Jun; 33(23):3014-23. PubMed ID: 23831570
[TBL] [Abstract][Full Text] [Related]
25. miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.
Huang CY; Huang XP; Zhu JY; Chen ZG; Li XJ; Zhang XH; Huang S; He JB; Lian F; Zhao YN; Wu GB
Oncol Rep; 2015 Jun; 33(6):2889-98. PubMed ID: 25962360
[TBL] [Abstract][Full Text] [Related]
26. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.
Chen X; Hao B; Han G; Liu Y; Dai D; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
J Cell Biochem; 2015 Feb; 116(2):225-32. PubMed ID: 25160587
[TBL] [Abstract][Full Text] [Related]
27. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
28. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
29. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
[TBL] [Abstract][Full Text] [Related]
30. miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.
Yu SH; Zhang CL; Dong FS; Zhang YM
J Cell Biochem; 2015 Feb; 116(2):268-76. PubMed ID: 25187230
[TBL] [Abstract][Full Text] [Related]
31. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
Lu W; Xu Z; Zhang M; Zuo Y
Int J Clin Exp Pathol; 2014; 7(10):7286-96. PubMed ID: 25400827
[TBL] [Abstract][Full Text] [Related]
32. miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1.
Wang R; Ma Y; Yu D; Zhao J; Ma P
Biomed Pharmacother; 2015 Mar; 70():64-71. PubMed ID: 25776481
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.
Du WW; Fang L; Li M; Yang X; Liang Y; Peng C; Qian W; O'Malley YQ; Askeland RW; Sugg SL; Qian J; Lin J; Jiang Z; Yee AJ; Sefton M; Deng Z; Shan SW; Wang CH; Yang BB
J Cell Sci; 2013 Mar; 126(Pt 6):1440-53. PubMed ID: 23418360
[TBL] [Abstract][Full Text] [Related]
34. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration.
Li H; Zhao J; Zhang JW; Huang QY; Huang JZ; Chi LS; Tang HJ; Liu GQ; Zhu DJ; Ma WM
Neoplasma; 2013; 60(5):511-5. PubMed ID: 23790169
[TBL] [Abstract][Full Text] [Related]
36. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.
Zhao X; Dou W; He L; Liang S; Tie J; Liu C; Li T; Lu Y; Mo P; Shi Y; Wu K; Nie Y; Fan D
Oncogene; 2013 Mar; 32(11):1363-72. PubMed ID: 22614005
[TBL] [Abstract][Full Text] [Related]
38. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
[TBL] [Abstract][Full Text] [Related]
39. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
